Associated Papers
Multiple clinical characteristics separate MED12-mutation-positive and -negative uterine leiomyomas.
Heinonen HR et al.
Scientific Reports, 2017
28432313 (PubMed )
Supplement: 41598_2017_1199_MOESM1_ESM.pdf
MED12 somatic mutations in fibroadenomas and phyllodes tumours of the breast.
Piscuoglio S et al.
Histopathology, 2015
Molecular topography of the MED12-deleted region in smooth muscle tumors: a possible link between non-B DNA structures and hypermutability.
Markowski DN et al.
Molecular Cytogenetics, 2013
MED12, the mediator complex subunit 12 gene, is mutated at high frequency in uterine leiomyomas.
Mäkinen N et al.
Science (new York, N.y.), 2011
Select a paper to view details